MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11684-023-1037-3

Медицинская библиотека · Frontiers of medicine · 2024

Small-molecule anti-COVID-19 drugs and a focus on China's homegrown mindeudesivir (VV116).

Cao Qiuyu, Ding Yi, Xu Yu, Li Mian, Zheng Ruizhi, Cao Zhujun, Wang Weiqing, Bi Yufang, Ning Guang, Xu Yiping, Zhao Ren

СтатьяОбзорПеревод в очереди

Аннотация

The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous efforts to develop therapeutic agents that target severe acute respiratory syndrome coronavirus 2 to control viral infection. So far, a few small-molecule antiviral drugs, including nirmatrelvir-ritonavir (Paxlovid), remdesivir, and molnupiravir have been marketed for the treatment of COVID-19. Nirmatrelvir-ritonavir has been recommended by the World Health Organization as an early treatment for outpatients with mild-to-moderate COVID-19. However, the existing treatment options have limitations, and effective treatment strategies that are cost-effective and convenient for tackling COVID-19 are still needed. To date, four domestically developed oral anti-COVID-19 drugs have been granted conditional market approval in China. These drugs include azvudine, simnotrelvir-ritonavir (Xiannuoxin), leritrelvir, and mindeudesivir (VV116). Preclinical and clinical studies have explored the efficacy and tolerability of mindeudesivir and supported its early use in mild-to-moderate COVID-19 cases at high risk for progression. In this review, we discuss the most recent findings regarding the pharmacological mechanism and therapeutic effects focusing on mindeudesivir and other small-molecule antiviral agents for COVID-19. These findings will expand our understanding and highlight the potential widespread application of China's homegrown anti-COVID-19 drugs.

Для цитирования: Cao Qiuyu, Ding Yi, Xu Yu, Li Mian, Zheng Ruizhi, Cao Zhujun, Wang Weiqing, Bi Yufang, Ning Guang, Xu Yiping, Zhao Ren. Small-molecule anti-COVID-19 drugs and a focus on China's homegrown mindeudesivir (VV116).. Frontiers of medicine. 2024. DOI: 10.1007/s11684-023-1037-3.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.